Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development
Jie Feng, Niall M. Byrne, Wafa Al Jamal, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1989-1989
Open Access | Times Cited: 23

Showing 23 citing articles:

Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
Bin Wang, Qin Zhao, Yuyu Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 224
Cancer-Associated Angiogenesis: The Endothelial Cell as a Checkpoint for Immunological Patrolling
Antonio Giovanni Solimando, Simona De Summa, Angelo Vacca, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3380-3380
Open Access | Times Cited: 84
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Rahul P. Bakshi, Lee Tatham, Alison C. Savage, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 80
Glycosylation of Methylflavonoids in the Cultures of Entomopathogenic Filamentous Fungi as a Tool for Obtaining New Biologically Active Compounds
Agnieszka Krawczyk-Łebek, Monika Dymarska, Tomasz Janeczko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5558-5558
Open Access | Times Cited: 23
Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance
Vishwajeet M. Khot, Ashwini B. Salunkhe, Sabrina Pricl, et al.
Drug Discovery Today (2020) Vol. 26, Iss. 3, pp. 724-739
Open Access | Times Cited: 37
The Role of ERα and ERβ in Castration-Resistant Prostate Cancer and Current Therapeutic Approaches
Nur Erysha Sabrina Jefferi, Asma’ ‘Afifah Shamhari, Nur Khayrin Zulaikha Noor Azhar, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 826-826
Open Access | Times Cited: 12
Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives
Prashant S. Kharkar
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 15279-15307
Closed Access | Times Cited: 32
Circular RNA and tumor microenvironment
Huixin Song, Qiaofei Liu, Quan Liao
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 30
Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression
Zhuang Chen, Rui Yuan, Shengyun Hu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Polysaccharides as therapeutic vehicles in pancreatic cancer
Seema Kumari, Sujatha Peela, Ganji Purnachandra Nagaraju, et al.
Drug Discovery Today (2025), pp. 104320-104320
Closed Access
Mechanical Forces in Tumor Growth and Treatment: Perspectives From Biology, Physics, Engineering, and Mathematical Modeling
Farshad Moradi Kashkooli, Fatemeh Mirala, Masoud H.H. Tehrani, et al.
WIREs Mechanisms of Disease (2025) Vol. 17, Iss. 2
Closed Access
Preparation and characterization of a gemini surfactant-based biomimetic complex for gene delivery
Lu Zhou, Zongjie Gan, Qianyu Zhang, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2022) Vol. 182, pp. 92-102
Closed Access | Times Cited: 13
Anterior gradient�2 as a supervisory marker for tumor vessel normalization induced by anti‑angiogenic treatment
Fan Pan, Wei Li, Wende Yang, et al.
Oncology Letters (2018)
Open Access | Times Cited: 16
Exploring near-infrared absorbing nanocarriers to overcome cancer drug resistance
Siwei Chu, Ursula Stochaj
Cancer Drug Resistance (2020)
Open Access | Times Cited: 14
Engineering the Tumor Immune Microenvironment through Minimally Invasive Interventions
Koustav Pal, Rahul A. Sheth
Cancers (2022) Vol. 15, Iss. 1, pp. 196-196
Open Access | Times Cited: 9
The Role of Epithelial-to-Mesenchymal Transition in Cutaneous Squamous Cell Carcinoma
María Teresa Fernández‐Figueras, L. Puig
Current Treatment Options in Oncology (2020) Vol. 21, Iss. 6
Closed Access | Times Cited: 11
Research Progress on Circular RNA in Glioma
Mengyu Chen, Chunyan Yan, Xihe Zhao
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 10
The prospects of nanotherapeutic approaches for targeting tumor-associated macrophages in oral cancer
Dwaipayan Bhattacharya, Kalyani Sakhare, Kumar Pranav Narayan, et al.
Nanomedicine Nanotechnology Biology and Medicine (2021) Vol. 34, pp. 102371-102371
Closed Access | Times Cited: 8
Combined Therapy with microRNA-Expressing Salmonella and Irradiation in Melanoma
Wonsuck Yoon, Yongsung Park, Seunghyun Kim, et al.
Microorganisms (2021) Vol. 9, Iss. 11, pp. 2408-2408
Open Access | Times Cited: 5
Cancer Nanomedicine
Clare Hoskins
Cancers (2020) Vol. 12, Iss. 8, pp. 2127-2127
Open Access | Times Cited: 5
Fabrication of polymeric nanomaterials for phototheranostics of cancer
Muralidharan Manjusha, Madhavan Yasasve, Geetha Sravanthy, et al.
Elsevier eBooks (2024), pp. 141-170
Closed Access
Biomimetic Nanotherapeutics Based on Oxygen Supply and Ultrasmall Cu-Se-Au Alloy Nanoparticles for Boosting Radio-Photothermal Ablation of Breast Cancer
Zhaoyang Guo, Yujia Xin, Lan Yang, et al.
SSRN Electronic Journal (2022)
Closed Access
Role of Electrospun Nanofibers in Cancer Detection and Treatment
Lohitha Kalluri, Yuanyuan Duan
Springer eBooks (2022), pp. 261-275
Closed Access
Page 1

Scroll to top